Tapewire

Nasdaq · USD

BEAT

HeartBeam, Inc.

Export transactions ↓
Tapewire entity
9039
SEC CIK
0001779372
Parsed reports
131

Last 12 months

Inside the activity.

9 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202600
Feb 202600
Mar 202600
Apr 202690
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantStock Option (right to buy) · Derivative 93,750 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001213900-26-108491 · ownership.xml · derivative · entry 2

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires 2036-10-02

F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantRestricted Stock Units · Derivative 93,750 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108491 · ownership.xml · derivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantStock Option (Right to Buy) · Derivative 125,000 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 3

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2036-10-02

F4 · derivative.exercise_date: Represents a nonqualified stock option granted to the Reporting Person on October 2, 2026 under the Plan in connection with the Reporting Person's additional responsibilities as Chair of the Board. One-twelfth of the shares subject to the option vest on each monthly anniversary of July 1, 2026, such that 3/12ths of the shares subject to the option were vested on the grant date and the option will be fully vested on July 1, 2027, subject to the Reporting Person's continued service as a director through each vesting date.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantRestricted Stock Units · Derivative 90,625 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 2

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,625

Underlying: Common Stock · 90,625 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantRestricted Stock Units · Derivative 125,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108490 · ownership.xml · derivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantRestricted Stock Units · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108489 · ownership.xml · derivative · entry 2

JAFF MICHAEL R · CIK 0001988352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:22 UTC GrantRestricted Stock Units · Derivative 93,750 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108489 · ownership.xml · derivative · entry 1

JAFF MICHAEL R · CIK 0001988352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantStock Option (right to buy) · Derivative 81,250 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001213900-26-108488 · ownership.xml · derivative · entry 2

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,250

Underlying: Common Stock · 81,250 shares

Expires 2036-10-02

F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantRestricted Stock Units · Derivative 93,750 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108488 · ownership.xml · derivative · entry 1

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantRestricted Stock Units · Derivative 31,250 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108487 · ownership.xml · derivative · entry 2

Nelson Kenneth Warwick III · CIK 0001981293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Stock · 31,250 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.

F3 · derivative.exercise_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

F3 · derivative.expiration_date: Represents a special RSU award granted to the Reporting Person on October 2, 2026 under the Plan in connection with the suspension of cash retainers for the period of July 1, 2026 through December 31, 2026. One-half of the RSUs vested on the grant date, and the remaining RSUs will vest on January 1, 2027, subject to the Reporting Person's continued service as a director through the vesting date. All unvested RSUs will vest in full immediately prior to a Change in Control (as defined in the Plan), subject to the Reporting Person's continued service as a director through such date.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantRestricted Stock Units · Derivative 93,750 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108487 · ownership.xml · derivative · entry 1

Nelson Kenneth Warwick III · CIK 0001981293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantStock Option (Right to Buy) · Derivative 93,750 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires 2036-10-02

F3 · derivative.exercise_date: The stock option was granted on October 2, 2026 under the Plan. The option vests as to one-half (1/2) of the underlying shares on the grant date, and as to the remaining one-half (1/2) on January 1, 2027, subject to the Reporting Person's continued service as a non-employee director through the applicable vesting date, with full acceleration of any then-unvested shares immediately prior to a Change in Control (as defined in the Plan).

Read SEC document
October 02, 2026 Filed Oct 9, 2026 20:21 UTC GrantRestricted Stock Units · Derivative 93,750 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-108486 · ownership.xml · derivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,750

Underlying: Common Stock · 93,750 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.

F2 · derivative.exercise_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

F2 · derivative.expiration_date: The RSUs were granted on October 2, 2026 under the Issuer's 2022 Equity Incentive Plan, as amended (the "Plan"), as an annual RSU award to non-employee directors. One hundred percent (100%) of the RSUs will vest on the earlier of October 2, 2027 or the date of the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service as a non-employee director through the vesting date. Vested RSUs will be settled in shares of common stock. RSUs do not expire.

Read SEC document
July 24, 2026 Filed Jul 24, 2026 20:54 UTC GrantCommon Stock 167,760 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-081455 · ownership.xml · nonDerivative · entry 1

Cruickshank Tim · CIK 0002038418 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 239,990

F1 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.

Read SEC document
July 24, 2026 Filed Jul 24, 2026 20:55 UTC
Persen Kenneth HarryChief Technology Officer
GrantCommon Stock 105,740 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-081458 · ownership.xml · nonDerivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 448,290

F1 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.

Read SEC document
July 24, 2026 Filed Jul 24, 2026 20:53 UTC
Vajdic BranislavDirector · President
GrantCommon Stock 260,870 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-081450 · ownership.xml · nonDerivative · entry 2

Vajdic Branislav · CIK 0001422425 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,970,784

F2 · shares: Represents Restricted Stock Units ("RSUs") granted on July 24, 2026 under the HeartBeam, Inc. 2022 Equity Incentive Plan. The RSUs vested in full on the grant date and relate to the settlement of the 2025 Bonus Program, whereby Executives received shares-in-lieu-of-cash.

Read SEC document
June 15, 2026 Filed Jul 24, 2026 20:53 UTC
Vajdic BranislavDirector · President
GrantCommon Stock 2,800,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-081450 · ownership.xml · nonDerivative · entry 1

Vajdic Branislav · CIK 0001422425 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,709,914

F1 · shares: Represents the grant of 2,800,000 performance-based restricted stock units ("PRSUs") under the HeartBeam, Inc. 2022 Equity Incentive Plan on June 15, 2026. The PRSUs are subject to performance-based milestones and service-based vesting conditions over a three-year period. Each PRSU represents a contingent right to receive one share of Common Stock upon vesting.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:46 UTC PurchaseCommon Stock 750,000 $0.80 $600,000.00
Disclosure

SEC source: 0001213900-26-044832 · ownership.xml · nonDerivative · entry 1

STROME MARK E · CIK 0000919484 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 3,650,000

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

F2 · ownership.nature: The reported securities are held directly by Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:47 UTC PurchaseCommon Stock 62,500 $0.80 $50,000.00
Disclosure

SEC source: 0001213900-26-044835 · ownership.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,636

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:48 UTC PurchaseCommon Stock 31,250 $0.80 $25,000.00
Disclosure

SEC source: 0001213900-26-044841 · ownership.xml · nonDerivative · entry 1

Cruickshank Tim · CIK 0002038418 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,230

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

F2 · balance_after: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 3, 2025.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:46 UTC PurchaseCommon Stock 25,000 $0.80 $20,000.00
Disclosure

SEC source: 0001213900-26-044833 · ownership.xml · nonDerivative · entry 1

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,293

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:47 UTC PurchaseCommon Stock 31,250 $0.80 $25,000.00
Disclosure

SEC source: 0001213900-26-044837 · ownership.xml · nonDerivative · entry 1

Vajdic Branislav · CIK 0001422425 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 909,914

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:48 UTC PurchaseCommon Stock 187,500 $0.80 $150,000.00
Disclosure

SEC source: 0001213900-26-044840 · ownership.xml · nonDerivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 538,667

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:47 UTC PurchaseCommon Stock 31,250 $0.80 $25,000.00
Disclosure

SEC source: 0001213900-26-044838 · ownership.xml · nonDerivative · entry 1

JAFF MICHAEL R · CIK 0001988352 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 31,250

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

F2 · ownership.direct: The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare.

F2 · ownership.nature: The shares are indirectly held by the Reporting Person under the entity Open Book Healthcare.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 00:47 UTC PurchaseCommon Stock 12,500 $0.80 $10,000.00
Disclosure

SEC source: 0001213900-26-044834 · ownership.xml · nonDerivative · entry 1

ENO Robert Paul · CIK 0001963418 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,742

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026.

F2 · balance_after: Includes 23,333 RSUs which have vested as per the Form 4 filed on October 2, 2025.

Read SEC document
April 16, 2026 Filed Apr 24, 2026 20:05 UTC Amendment PurchaseCommon Stock 57,500 $0.80 $46,000.00
Disclosure

SEC source: 0001213900-26-047514 · ownership.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,636

F1 · shares: These shares were purchased in connection with the Registrant's underwritten public offering of 12,500,000 shares of common stock. Titan Partners, a division of American Capital Partners, acted as the sole bookrunner for the offering, which priced on April 14, 2026, and closed on April 16, 2026. This amendment restates the Reporting Person's original Form 4 filed on April 16, 2026, solely to correct an inadvertent error in the number of shares of common stock reported as acquired and the corresponding total beneficial ownership. The original filing reported the acquisition of 62,500 shares of common stock. The correct number of shares acquired was 57,500 shares of common stock. No other changes have been made to the original filing.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:38 UTC
STROME MARK E10% owner
GrantCommon Stock (right to buy) · Derivative 41,380 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001213900-26-033043 · ownership.xml · derivative · entry 1

STROME MARK E · CIK 0000919484 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,380

Underlying: Common Stock · 41,380 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:38 UTC GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-033045 · ownership.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,136

F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:35 UTC GrantCommon Stock (right to buy) · Derivative 53,104 $0.00 Strike: $1.45 $0.00
Disclosure

SEC source: 0001213900-26-033034 · ownership.xml · derivative · entry 1

Cruickshank Tim · CIK 0002038418 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,104

Underlying: Common Stock · 53,104 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:39 UTC GrantCommon Stock(right to buy) · Derivative 44,827 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001213900-26-033048 · ownership.xml · derivative · entry 1

Ortigas-Wedekind Marga · CIK 0001453971 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,827

Underlying: Common Stock · 44,827 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:36 UTC
Vajdic BranislavDirector · President
GrantCommon Stock (right to buy) · Derivative 61,932 $0.00 Strike: $1.45 $0.00
Disclosure

SEC source: 0001213900-26-033038 · ownership.xml · derivative · entry 1

Vajdic Branislav · CIK 0001422425 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,932

Underlying: Common Stock · 61,932 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 17:31 UTC GrantCommon Stock (right to buy) · Derivative 51,724 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001213900-26-033025 · ownership.xml · derivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,724

Underlying: Common Stock · 51,724 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:37 UTC GrantCommon Stock 20,689 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-033041 · ownership.xml · nonDerivative · entry 1

JAFF MICHAEL R · CIK 0001988352 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,809

F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:34 UTC GrantCommon Stock (right to buy) · Derivative 51,724 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001213900-26-033031 · ownership.xml · derivative · entry 1

Elfrink Willem · CIK 0001893194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,724

Underlying: Common Stock · 51,724 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:33 UTC GrantCommon Stock 17,241 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-033029 · ownership.xml · nonDerivative · entry 1

Nelson Kenneth Warwick III · CIK 0001981293 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,388

F1 · ownership.direct: These securities are restricted stock units (RSUs). Granted on February 9, 2026 (the "Special RSU"), one half of the total number of shares of common stock ("Shares") subject to the Special RSU shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning on January 1, 2026, and the remaining Shares subject to the Special RSU shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These RSUs have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 09, 2026 Filed Mar 23, 2026 21:29 UTC GrantCommon Stock (right to buy) · Derivative 55,172 $0.00 Strike: $1.45 $0.00
Disclosure

SEC source: 0001213900-26-033021 · ownership.xml · derivative · entry 1

ENO Robert Paul · CIK 0001963418 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,172

Underlying: Common Stock · 55,172 shares

Expires 2036-01-01

F1 · derivative.exercise_date: Granted options on February 9, 2026 (the "Special Option"), one half of the total number of shares of common stock (the "Shares") subject to the Special Option shall vest on March 31, 2026, the three-month anniversary of the vesting commencement date beginning January 1, 2026, and the remaining Shares of common stock shall vest on June 30, 2026, the six-month anniversary of the vesting commencement date. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 17:10 UTC SaleCommon Stock 33,185 $2.83 $93,913.55
Disclosure

SEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 17:10 UTC SaleCommon Stock 23,961 $3.68 $88,176.48
Disclosure

SEC source: 0001213900-25-123939 · ownership.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,185

F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

Read SEC document
December 17, 2025 Filed Dec 22, 2025 22:44 UTC
STROME MARK E10% owner
SaleCommon Stock 250,000 $3.58 $895,000.00
Disclosure

SEC source: 0001213900-25-124693 · ownership.xml · nonDerivative · entry 1

STROME MARK E · CIK 0000919484 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 2,900,000

F1 · balance_after: The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.nature: The reported securities are held directly by Mark E. Strome Living Trust and Strome Dynasty, LLC. Mr. Strome has the authority to vote and dispose of the reported securities held by each of these entities. Mr. Strome disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that Mr. Strome is a beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Read SEC document
April 07, 2025 Filed May 1, 2025 15:06 UTC
Cruickshank TimChief Financial Officer
GrantCommon Stock (right to buy) · Derivative 150,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001213900-25-038175 · ownership.xml · derivative · entry 1

Cruickshank Tim · CIK 0002038418 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 550,000

Underlying: Common Stock · 150,000 shares

Expires 2035-04-07

F1 · derivative.exercise_date: Granted 150,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
April 07, 2025 Filed May 1, 2025 15:03 UTC
Persen Kenneth HarryChief Technology Officer
GrantStock option (right to buy) · Derivative 20,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001213900-25-038171 · ownership.xml · derivative · entry 1

Persen Kenneth Harry · CIK 0001942350 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 441,000

Underlying: Common Stock · 20,000 shares

Expires 2035-04-07

F1 · derivative.exercise_date: Granted 20,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 07, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
April 07, 2025 Filed May 1, 2025 15:03 UTC
Vajdic BranislavDirector · President
GrantStock option (right to buy) · Derivative 180,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001213900-25-038170 · ownership.xml · derivative · entry 1

Vajdic Branislav · CIK 0001422425 · Director · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,374,000

Underlying: Common Stock · 180,000 shares

Expires 2035-04-07

F1 · derivative.exercise_date: Granted 180,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
April 07, 2025 Filed May 1, 2025 15:05 UTC
ENO Robert PaulChief Executive Officer
GrantStock option (right to buy) · Derivative 320,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001213900-25-038173 · ownership.xml · derivative · entry 1

ENO Robert Paul · CIK 0001963418 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 856,000

Underlying: Common Stock · 320,000 shares

Expires 2035-04-07

F1 · derivative.exercise_date: Granted 320,000 options on April 7, 2025, which are scheduled to vest over 4 years with 25% vesting on April 7, 2025, and the remainder vesting and exercisable monthly thereafter. These options have been issued from the Company's 2022 Equity Incentive Plan.

Read SEC document
February 14, 2025 Filed Feb 22, 2025 01:00 UTC PurchaseCommon Stock 29,412 $1.70 $50,000.40
Disclosure

SEC source: 0001628280-25-007240 · wk-form4_1740186016.xml · nonDerivative · entry 1

Ferrari Richard · CIK 0001034413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 179,136

F1 · shares: These shares were purchased in the Issuers offering which closed on February 14, 2025

Read SEC document
February 14, 2025 Filed Feb 22, 2025 00:55 UTC PurchaseCommon Stock 17,647 $1.70 $29,999.90
Disclosure

SEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · nonDerivative · entry 1

Cruickshank Tim · CIK 0002038418 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,647

F1 · shares: These shares were purchased in the Issuers offering which closed on February 14, 2025

Read SEC document
September 25, 2024 Filed Feb 22, 2025 00:55 UTC GrantCommon Stock (right to buy) · Derivative 400,000 $2.28 Strike: $2.28 $912,000.00
Disclosure

SEC source: 0001628280-25-007239 · wk-form4_1740185708.xml · derivative · entry 2

Cruickshank Tim · CIK 0002038418 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2034-09-25

F2 · derivative.exercise_date: Granted 400,000 options on September 25, 2024, which are scheduled to vest over 4 years with 25% vesting on September 26, 2025, and the remainder vesting and exercisable monthly thereafter.

Read SEC document
September 06, 2024 Filed Sep 11, 2024 16:36 UTC SaleCommon Stock 1,674 $2.34 $3,917.16
Disclosure

SEC source: 0001628280-24-040139 · wk-form4_1726086999.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,146

F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 18:25 UTC SaleCommon Stock 5,500 $2.31 $12,705.00
Disclosure

SEC source: 0001628280-24-039383 · wk-form4_1725485085.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,820

F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

Read SEC document
August 27, 2024 Filed Aug 29, 2024 16:18 UTC SaleCommon Stock 2,194 $2.26 $4,958.44
Disclosure

SEC source: 0001628280-24-038817 · wk-form4_1724962716.xml · nonDerivative · entry 1

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,320

F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

Read SEC document
August 26, 2024 Filed Aug 27, 2024 15:07 UTC SaleCommon Stock 300 $2.38 $714.00
Disclosure

SEC source: 0001628280-24-038522 · wk-form4_1724785648.xml · nonDerivative · entry 2

de Urioste George · CIK 0001270068 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,514

F1 · ownership.direct: These shares were sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) which vested in favor of the Reporting Person on the date of the Issuer's 2024 annual meeting of stockholders, which was held on June 12, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.